Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Shares Outstanding (Diluted Average): 2021-2025

Historic Shares Outstanding (Diluted Average) for Benitec Biopharma (BNTC) over the last 4 years, with Mar 2025 value amounting to $38.6 million.

  • Benitec Biopharma's Shares Outstanding (Diluted Average) rose 111.13% to $38.6 million in Q1 2025 from the same period last year, while for Mar 2025 it was $38.6 million, marking a year-over-year increase of 111.13%. This contributed to the annual value of $18.4 million for FY2024, which is 1225.17% up from last year.
  • Benitec Biopharma's Shares Outstanding (Diluted Average) amounted to $38.6 million in Q1 2025, which was up 3.61% from $37.3 million recorded in Q4 2024.
  • Over the past 5 years, Benitec Biopharma's Shares Outstanding (Diluted Average) peaked at $38.6 million during Q1 2025, and registered a low of $480,688 during Q2 2022.
  • Over the past 3 years, Benitec Biopharma's median Shares Outstanding (Diluted Average) value was $18.3 million (recorded in 2024), while the average stood at $16.5 million.
  • Per our database at Business Quant, Benitec Biopharma's Shares Outstanding (Diluted Average) crashed by 92.19% in 2022 and then spiked by 1,346.03% in 2024.
  • Over the past 5 years, Benitec Biopharma's Shares Outstanding (Diluted Average) (Quarterly) stood at $8.2 million in 2021, then slumped by 80.16% to $1.6 million in 2022, then skyrocketed by 58.91% to $2.6 million in 2023, then skyrocketed by 1,346.03% to $37.3 million in 2024, then soared by 111.13% to $38.6 million in 2025.
  • Its last three reported values are $38.6 million in Q1 2025, $37.3 million for Q4 2024, and $27.9 million during Q3 2024.